Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Zeiss to Acquire Xradia to Expand its Microscopy Market

By BiotechDaily International staff writers
Posted on 24 Jun 2013
Zeiss (Oberkochen, Germany), an international leader of optics and optoelectronics systems recently reported on the acquisition of Xradia, Inc. (Pleasanton, CA, USA), which is expected to expand the company from light and electron microscopy into X-ray microscopy technology.

Xradia is a medium-size company that developed innovative three-dimensional (3D) X-ray microscopes for academic and industrial research purposes.

Xradia, Inc., after closing the deal, will operate under the new name Carl Zeiss X-ray Microscopy, Inc.

Related Links:
Zeiss
Xradia


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.